Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:INOV

Inovalon (INOV) Stock Price, News & Analysis

Inovalon logo

About Inovalon Stock (NASDAQ:INOV)

Key Stats

Today's Range
$28.48
$28.63
50-Day Range
$40.66
$41.06
52-Week Range
$17.56
$41.06
Volume
8,952 shs
Average Volume
720,587 shs
Market Capitalization
$4.43 billion
P/E Ratio
84.01
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.

Receive INOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter.

INOV Stock News Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More Headlines

INOV Stock Analysis - Frequently Asked Questions

Inovalon Holdings, Inc. (NASDAQ:INOV) released its earnings results on Wednesday, July, 28th. The technology company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to the consensus estimate of $183.89 million. Inovalon had a trailing twelve-month return on equity of 10.97% and a net margin of 6.73%.

Inovalon (INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inovalon investors own include NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Moderna (MRNA), Block (SQ), Meta Platforms (META) and PayPal (PYPL).

Company Calendar

Last Earnings
7/28/2021
Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Data Processing & Preparation
Sub-Industry
N/A
Current Symbol
NASDAQ:INOV
Employees
1,836
Year Founded
N/A

Profitability

Net Income
$22.58 million
Pretax Margin
5.86%

Debt

Sales & Book Value

Annual Sales
$667.52 million
Cash Flow
$0.86 per share
Book Value
$4.94 per share

Miscellaneous

Free Float
78,011,000
Market Cap
$4.43 billion
Optionable
No Data
Beta
0.53

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:INOV) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners